Nucleus Genomics lands new funding from Alexis Ohanian to help people assess specific disease risks
Nucleus Genomics, a genetic testing company focused on calculating a patient’s risk of certain diseases, is adding $14 million to their initial seed funding round. With this round the company has raised, in total, $17.5 million. This “seed plus” funding round was led by Alexis Ohanian’s 776. Ohanian is joining investors like Founders Fund, Adrian […]
Read more